Xanomeline (oxalate)

Xanomeline oxalate (LY246708 oxalate) is a potent and selective muscarinic receptor agonist (SMRA) and stimulates phosphoinositide hydrolysis in vivo. Xanomeline oxalate can be used for the research of Alzheimer’s disease[1].

Product Specifications

CAS Number

[141064-23-5]

Product Name Alternative

LY246708 (oxalate)

UNSPSC

12352005

Hazard Statement

H301, H312, H330, H410

Target

MAChR

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/Xanomeline-oxalate.html

Purity

99.93

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

CN1CCC=C(C2=NSN=C2OCCCCCC)C1.O=C(O)C(O)=O

Molecular Formula

C16H25N3O5S

Molecular Weight

371.45

Precautions

H301, H312, H330, H410

References & Citations

[1]F P Bymaster, et al. Xanomeline Compared to Other Muscarinic Agents on Stimulation of Phosphoinositide Hydrolysis in Vivo and Other Cholinomimetic Effects. Brain Res. 1998 Jun 8; 795 (1-2) :179-90.